Controlled Clinical Trials

Aims & Scope

Continued as Contemporary Clinical Trials.

Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics.

Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics.

Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published.

Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.

Contemporary Clinical Trials is unique in that it is outside the confines of disease specifications, and it strives to adapt and grow with an expanding clinical trials landscape as the needs of clinical research evolve in today's dynamic healthcare environment.

Having taken upon the important role as a platform for knowledge exchange between experts in different disciplines related to clinical trials, the ultimate goal of Contemporary Clinical Trials is to advance this field of research for the benefit of patients.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Meta-analysis in clinical trials

  Citation: 31745

  Authors: Rebecca, Nan

• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

  Citation: 13677

  Authors: Alejandro R., R.Andrew, Dawn, Crispin, D.John M., David J., Henry J.

• Measurement of health status

  Citation: 3874

  Authors: Roman, Joel, Gordon H.

• Optimal two-stage designs for phase II clinical trials

  Citation: 3118

  Authors: Richard

• Design of the Women’s Health Initiative Clinical Trial and Observational Study

  Citation: 2192

  Authors:

• A note on quantifying follow-up in studies of failure time

  Citation: 2167

  Authors: Michael, Terry L.

• Power and sample size calculations

  Citation: 1590

  Authors: William D., Walton D.

• Reproducibility and responsiveness of health status measures statistics and strategies for evaluation

  Citation: 1066

  Authors: Richard A., Paula, Donald L.

• A method for assessing the quality of a randomized control trial

  Citation: 1008

  Authors: Thomas C., Harry, Bradley, Bernard, Biruta, Dinah, Alexander

• Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists

  Citation: 865

  Authors: David, Alejandro R, Graham, Marie, Peter, Sharon